IN8bio (INAB)
(Delayed Data from NSDQ)
$1.05 USD
+0.05 (5.00%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $0.98 -0.07 (-6.67%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.05 USD
+0.05 (5.00%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $0.98 -0.07 (-6.67%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Here's Why IN8bio, Inc. (INAB) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
IN8bio, Inc. (INAB) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
IN8bio, Inc. (INAB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IN8bio, Inc. (INAB) Is Up 37.87% in One Week: What You Should Know
by Zacks Equity Research
Does IN8bio, Inc. (INAB) have what it takes to be a top stock pick for momentum investors? Let's find out.